Literature DB >> 15644868

Modulation of voltage-gated channel currents by harmaline and harmane.

Frank Splettstoesser1, Udo Bonnet, Martin Wiemann, Dieter Bingmann, Dietrich Büsselberg.   

Abstract

Harmala alkaloids are endogenous substances, which are involved in neurodegenerative disorders such as M. Parkinson, but some of them also have neuroprotective effects in the nervous system. While several sites of action at the cellular level (e.g. benzodiazepine receptors, 5-HT and GABA(A) receptors) have been identified, there is no report on how harmala alkaloids interact with voltage-gated membrane channels. The aim of this study was to investigate the effects of harmaline and harmane on voltage-activated calcium- (I(Ca(V))), sodium- (I(Na(V))) and potassium (I(K(V)))-channel currents, using the whole-cell patch-clamp method with cultured dorsal root ganglion neurones of 3-week-old rats. Currents were elicited by voltage steps from the holding potential to different command potentials. Harmaline and harmane reduced I(Ca(V)), I(Na(V)) and I(K(V)) concentration-dependent (10-500 microM) over the voltage range tested. I(Ca(V)) was reduced with an IC(50) of 100.6 microM for harmaline and by a significantly lower concentration of 75.8 microM (P<0.001, t-test) for harmane. The Hill coefficient was close to 1. Threshold concentration was around 10 microM for both substances. The steady state of inhibition of I(Ca(V)) by harmaline or harmane was reached within several minutes. The action was not use-dependent and at least partly reversible. It was mainly due to a reduction in the sustained calcium channel current (I(Ca(L+N))), while the transient voltage-gated calcium channel current (I(Ca(T))) was only partially affected. We conclude that harmaline and harmane are modulators of I(Ca(V)) in vitro. This might be related to their neuroprotective effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644868      PMCID: PMC1575976          DOI: 10.1038/sj.bjp.0706024

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Vasorelaxant effect of harman.

Authors:  C C Shi; S Y Chen; G J Wang; J F Liao; C F Chen
Journal:  Eur J Pharmacol       Date:  2000-03-03       Impact factor: 4.432

2.  Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells.

Authors:  D H Kim; Y Y Jang; E S Han; C S Lee
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

3.  The impact of smoking and drinking on plasma levels of norharman.

Authors:  Renske Spijkerman; Regina van den Eijnden; Dike van de Mheen; Inge Bongers; Durk Fekkes
Journal:  Eur Neuropsychopharmacol       Date:  2002-02       Impact factor: 4.600

4.  Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells.

Authors:  C S Lee; E S Han; Y Y Jang; J H Han; H W Ha; D E Kim
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

5.  Involvement of p38 mitogen-activated protein kinase and apoptosis signal-regulating kinase-1 in nitric oxide-induced cell death in PC12 cells.

Authors:  O J Han; K H Joe; S W Kim; H S Lee; N S Kwon; K J Baek; H Y Yun
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

6.  Novel selective compounds for the investigation of imidazoline receptors.

Authors:  A L Hudson; R Gough; R Tyacke; L Lione; M Lalies; J Lewis; S Husbands; P Knight; F Murray; P Hutson; D J Nutt
Journal:  Ann N Y Acad Sci       Date:  1999-06-21       Impact factor: 5.691

7.  Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices-implication for its neuroprotective properties.

Authors:  U Bonnet; T Leniger; M Wiemann
Journal:  Neuropharmacology       Date:  2000-08-23       Impact factor: 5.250

8.  Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients.

Authors:  W Kuhn; T Müller; M Gerlach; E Sofic; G Fuchs; N Heye; R Prautsch; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

9.  Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors.

Authors:  R A Glennon; M Dukat; B Grella; S Hong; L Costantino; M Teitler; C Smith; C Egan; K Davis; M V Mattson
Journal:  Drug Alcohol Depend       Date:  2000-08-01       Impact factor: 4.492

10.  Inhibitors of synaptosomal gamma-hydroxybutyrate transport.

Authors:  S J McCormick; G Tunnicliff
Journal:  Pharmacology       Date:  1998-09       Impact factor: 2.547

View more
  13 in total

1.  Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive.

Authors:  Young-Gyun Park; Hye-Yeon Park; C Justin Lee; Soonwook Choi; Seonmi Jo; Hansol Choi; Yang-Hann Kim; Hee-Sup Shin; Rodolfo R Llinas; Daesoo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

Review 2.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

3.  Screening an In-House Isoquinoline Alkaloids Library for New Blockers of Voltage-Gated Na+ Channels Using Voltage Sensor Fluorescent Probes: Hits and Biases.

Authors:  Quentin Coquerel; Claire Legendre; Jacinthe Frangieh; Stephan De Waard; Jérôme Montnach; Leos Cmarko; Joseph Khoury; Charifat Said Hassane; Dimitri Bréard; Benjamin Siegler; Ziad Fajloun; Harold De Pomyers; Kamel Mabrouk; Norbert Weiss; Daniel Henrion; Pascal Richomme; César Mattei; Michel De Waard; Anne-Marie Le Ray; Christian Legros
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

4.  Dietary effects of harmine, a β-carboline alkaloid, on development, energy reserves and α-amylase activity of Plodia interpunctella Hübner (Lepidoptera: Pyralidae).

Authors:  Noureddin Bouayad; Kacem Rharrabe; Mostafa Lamhamdi; Naima Ghailani Nourouti; Fouad Sayah
Journal:  Saudi J Biol Sci       Date:  2010-12-15       Impact factor: 4.219

5.  IP(3) receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis.

Authors:  F Splettstoesser; A-M Florea; D Büsselberg
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

6.  The Role of Hippocampal 5HT3 Receptors in Harmaline-Induced Memory Deficit.

Authors:  Mohammad Nasehi
Journal:  Basic Clin Neurosci       Date:  2015-07

7.  In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus.

Authors:  Mohammad-Taghi Moradi; Ali Karimi; Fatemeh Fotouhi; Soleiman Kheiri; Ali Torabi
Journal:  Avicenna J Phytomed       Date:  2017 Nov-Dec

8.  Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor.

Authors:  Adrian Handforth
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-12

Review 9.  Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids.

Authors:  Milad Moloudizargari; Peyman Mikaili; Shahin Aghajanshakeri; Mohammad Hossein Asghari; Jalal Shayegh
Journal:  Pharmacogn Rev       Date:  2013-07

Review 10.  The potential roles of T-type Ca2+ channels in motor coordination.

Authors:  Young-Gyun Park; Jeongjin Kim; Daesoo Kim
Journal:  Front Neural Circuits       Date:  2013-10-28       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.